Recurrent Erysipelas Trial Across 25 Locations in France
Summary
A Phase 4 clinical trial (NCT07549594) investigating interventions for recurrent erysipelas has been registered on ClinicalTrials.gov. The trial is conducted across 25 locations in France, indicating a multi-center study design. ClinicalTrials.gov is maintained by the National Library of Medicine, part of the National Institutes of Health, and serves as a public registry for clinical studies.
About this source
GovPing monitors ClinicalTrials.gov - Phase 4 Trials for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 17 changes logged to date.
What changed
This document adds a new clinical trial registration to the ClinicalTrials.gov database. The trial (NCT07549594) is a Phase 4 interventional study focused on recurrent erysipelas, conducted at 25 sites across France. Phase 4 trials represent post-marketing surveillance studies conducted after regulatory approval.
Healthcare providers and clinical investigators in France who may treat patients with recurrent erysipelas should be aware of this trial for potential patient referral opportunities. Pharmaceutical companies developing anti-infective therapies may find this trial relevant for competitive intelligence or partnership opportunities.
Archived snapshot
Apr 28, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Show glossary
Mentioned entities
Related changes
Get daily alerts for ClinicalTrials.gov - Phase 4 Trials
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov - Phase 4 Trials publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.